Reuven Agami
- Cancer Research top 0.05%
- MicroRNA in disease regulation 40
- Cancer-related molecular mechanisms research 23
- Molecular Biology top 0.1%
- RNA modifications and cancer 50
- RNA Research and Splicing 38
- RNA and protein synthesis mechanisms 21
- RNA Interference and Gene Delivery 15
- Genomics and Chromatin Dynamics 10
- Oncology top 1%
- Cancer-related Molecular Pathways 12
- Aging top 1%
- Cell Biology top 0.5%
- Co-authors
- René BernardsThijn R. BrummelkampCarlos le SageRan ElkonMartijn KeddeRemco NagelMariëtte SchrierP. Mathijs Voorhoeve
- Partner nations
- NetherlandsIsraelUnited States
In The Last Decade
Reuven Agami
124 papers receiving 19.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 7.5k
- Molecular Biology 16.6k
- Oncology 2.7k
- Aging 164
- Cell Biology 1.2k
Countries citing papers authored by Reuven Agami
This map shows the geographic impact of Reuven Agami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuven Agami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuven Agami more than expected).
Fields of papers citing papers by Reuven Agami
This network shows the impact of papers produced by Reuven Agami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuven Agami. The network helps show where Reuven Agami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Reuven Agami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 51 | |
| 4 | 2024 | 11 | |
| 5 | 2022 | 9 | |
| 6 | 2020 | 38 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 4 | |
| 9 | 2015 | 18 | |
| 10 | 2013 | 94 | |
| 11 | 2013 | 12 | |
| 12 | 2013 | 36 | |
| 13 | 2012 | 94 | |
| 14 | 2012 | 214 | |
| 15 | 2009 | 83 | |
| 16 | 2008 | 392 | |
| 17 | The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis | 2008 | 1 |
| 18 | RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNAbreakdown → | 2007 | 591 |
| 19 | A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumorsbreakdown → | 2006 | 1023 |
| 20 | 2005 | 220 |
About Reuven Agami
Reuven Agami is a scholar working on Cancer Research, Molecular Biology and Aging, having authored 127 papers that have together received 19.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (50 papers), MicroRNA in disease regulation (40 papers), RNA Research and Splicing (38 papers), Cancer-related molecular mechanisms research (23 papers), RNA and protein synthesis mechanisms (21 papers), RNA Interference and Gene Delivery (15 papers), Cancer-related Molecular Pathways (12 papers) and Genomics and Chromatin Dynamics (10 papers). The work is most often cited by research in Cancer Research (7.5k citations), Molecular Biology (16.6k citations) and Oncology (2.7k citations). Reuven Agami has collaborated with scholars based in Netherlands, Israel and United States. Frequent co-authors include René Bernards, Thijn R. Brummelkamp, Carlos le Sage, Ran Elkon, Martijn Kedde, Remco Nagel, Mariëtte Schrier, P. Mathijs Voorhoeve, Alejandro P. Ugalde and Joachim A.F. Oude Vrielink. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.